healthandpharma17h
A Breakthrough in Personalizing Lung Cancer Therapy with the GO Chip for Tumor Monitoring
The innovative GO chip, developed at the University of Michigan, represents a significant leap in lung cancer treatment by ...
healthandpharma19h
FDA Approves Tislelizumab Plus Chemotherapy for PD-L1+ Metastatic Esophageal Cancer
The FDA has approved Tislelizumab (Tevimbra) plus platinum-based chemotherapy as a first-line treatment for adult patients ...